Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-4,859
Closed -$1.4M 368
2023
Q4
$1.4M Buy
+4,859
New +$1.32M 0.03% 391
2023
Q3
Sell
-3,870
Closed -$966K 1065
2023
Q2
$859K Buy
+3,870
New +$898K 0.01% 480
2022
Q4
Sell
-6,454
Closed -$1.73M 830
2022
Q3
$1.46M Buy
+6,454
New +$1.56M 0.03% 400
2022
Q1
Sell
-2,332
Closed -$536K 960
2021
Q4
$525K Buy
+2,332
New +$492K 0.02% 544
2021
Q2
Sell
-2,595
Closed -$638K 1039
2021
Q1
$645K Sell
2,595
-2,857
-52% -$682K 0.03% 555
2020
Q4
$1.25M Buy
5,452
+2,490
+84% +$574K 0.12% 204
2020
Q3
$748K Buy
2,962
+251
+9% +$62.2K 0.06% 306
2020
Q2
$639K Buy
+2,711
New +$619K 0.04% 270
2019
Q4
Sell
-1,079
Closed -$238K 355
2019
Q3
$210K Buy
+1,079
New +$207K 0.07% 178

Other funds holding AMGN

Maven Securities's AMGN Position: Q1 2024 in Review

Maven Securities sold out of Amgen (AMGN) in Q1 2024, closing a stake of 4,859 shares — an estimated $1.4M sold.

Maven Securities first reported a position in AMGN in Q3 2019 and held it in 9 quarters. The position peaked at $1.46M in Q3 2022. 2,715 funds tracked by Wall St. Rank hold AMGN as of Q1 2024.

  • Maven Securities reported no remaining Amgen position as of Q1 2024 after selling out during the quarter.
  • Maven Securities sold 4,859 Amgen shares in Q1 2024, an estimated $1.4M.
  • Maven Securities first reported a position in Amgen in Q3 2019 and held it in 9 quarters.
  • Maven Securities's Amgen position peaked at $1.46M in Q3 2022.
  • 2,715 funds tracked by Wall St. Rank held Amgen as of Q1 2024.

Based on Maven Securities's 13F filing for Q1 2024, filed 14 May 2024.